Corrigendum to "Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and STAT3 pathways" [Arch. Biochem. Biophys. 575, (2015), 38-45].
- DOI
- 10.1016/j.abb.2026.110985
- Published
- 2026 Sep 15
- Container
- Archives of biochemistry and biophysics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.abb.2026.110985,
title = {Corrigendum to "Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and STAT3 pathways" [Arch. Biochem. Biophys. 575, (2015), 38-45].},
author = {Chen J and Lan T and Zhang W and Dong L and Kang N and Fu M and Liu B and Liu K and Zhang C and Hou J and Zhan Q},
year = {2026},
journal = {Archives of biochemistry and biophysics},
doi = {10.1016/j.abb.2026.110985},
url = {https://doi.org/10.1016/j.abb.2026.110985}
}RIS
TY - JOUR TI - Corrigendum to "Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and STAT3 pathways" [Arch. Biochem. Biophys. 575, (2015), 38-45]. AU - Chen J AU - Lan T AU - Zhang W AU - Dong L AU - Kang N AU - Fu M AU - Liu B AU - Liu K AU - Zhang C AU - Hou J AU - Zhan Q PY - 2026 JO - Archives of biochemistry and biophysics DO - 10.1016/j.abb.2026.110985 UR - https://doi.org/10.1016/j.abb.2026.110985 ER -
APA
J, C., T, L., W, Z., L, D., N, K., M, F., B, L., K, L., C, Z., J, H., & Q, Z. (2026). Corrigendum to "Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and STAT3 pathways" [Arch. Biochem. Biophys. 575, (2015), 38-45].. Archives of biochemistry and biophysics. https://doi.org/10.1016/j.abb.2026.110985
Source records
- pubmed · retrieved 2026-09-25T23:17:58.477Z